Compare · LUCY vs RXST
LUCY vs RXST
Side-by-side comparison of Innovative Eyewear Inc. (LUCY) and RxSight Inc. (RXST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LUCY and RXST operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- RXST is the larger of the two at $229.8M, about 44.6x LUCY ($5.1M).
- Over the past year, LUCY is down 62.2% and RXST is down 24.3% - RXST leads by 38.0 points.
- Both names hit the wire about 6 times in the past 4 weeks.
- RXST has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Innovative Eyewear Inc.
- RxSight Inc.
- Price
- $0.80-1.17%
- $5.56-0.36%
- Market cap
- $5.1M
- $229.8M
- 1M return
- -9.03%
- +19.31%
- 1Y return
- -62.24%
- -24.25%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2021
- News (4w)
- 6
- 6
- Recent ratings
- 0
- 25
RxSight Inc.
RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.
Latest LUCY
- Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear
- Innovative Eyewear Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds
- Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group
- Innovative Eyewear Q2 2026 Net Sales Up 71% Year-Over-Year in Twelfth Consecutive Quarter of Growth
- Innovative Eyewear, Inc. Partners with Encore Optical Laboratory to Provide New Lens Technologies for Smart Eyewear
- Innovative Eyewear Inc. Reports Q1 2026 Unaudited Financial Results
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear, Inc. Announces Real-Time AI Translated Calls for the Lucyd App
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
Latest RXST
- RxSight Inc. filed SEC Form 8-K: Regulation FD Disclosure
- RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
- RxSight Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- RxSight Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- Director Warner Robert Keith was granted 37,037 shares, increasing direct ownership by 90% to 78,076 units (SEC Form 4)
- Director Palmisano Robert J was granted 37,037 shares, increasing direct ownership by 90% to 78,076 units (SEC Form 4)
- Director Maniar Shweta was granted 37,037 shares, increasing direct ownership by 204% to 55,172 units (SEC Form 4)
- Director Fountain Tamara was granted 37,037 shares, increasing direct ownership by 104% to 72,582 units (SEC Form 4)